Equities

Eli Lilly and Co

0Q1G:LSE

Eli Lilly and Co

  • Price (CHF)460.00
  • Today's Change460.00 / --
  • Shares traded3.00
  • 1 Year change--
  • Beta0.4034
Data delayed at least 20 minutes, as of Sep 03 2025 15:29 BST.
More ▼

Financials data is unavailable for this security.

Inc stmt in USDIncome statement in USDView more

Year on year Eli Lilly and Co grew revenues 44.70% from 45.04bn to 65.18bn while net income improved 94.90% from 10.59bn to 20.64bn.
Gross margin83.04%
Net profit margin31.66%
Operating margin40.35%
Return on assets--
Return on equity--
Return on investment--
More ▼

Cash flow in USDView more

In 2024, Eli Lilly and Co increased its cash reserves by 15.96%, or 449.80m. The company earned 8.82bn from its operations for a Cash Flow Margin of 19.58%. In addition the company generated 1.23bn cash from financing while 9.30bn was spent on investing.
Cash flow per share17.14
Price/Cash flow per share62.61
Book value per share--
Tangible book value per share--
More ▼

Balance sheet in USDView more

SmartText is unavailable
Current ratio--
Quick ratio--
Total debt/total equity--
Total debt/total capital--
More ▼

Growth rates in USD

SmartText is unavailable
Div yield(5 year avg)0.75%
Div growth rate (5 year)15.18%
Payout ratio (TTM)13.04%
EPS growth(5 years)27.59
EPS (TTM) vs
TTM 1 year ago		95.89
More ▼
Data Provided by LSEG
All markets data located on InvestorsChronicle.co.uk is subject to the Investors Chronicle Terms & Condition
All content on InvestorsChronicle.co.uk is for your general information and use only and is not intended to address your particular requirements. In particular, the content does not constitute any form of advice, recommendation, representation, endorsement or arrangement by IC and is not intended to be relied upon by users in making (or refraining from making) any specific investment or other decisions.
Any information that you receive via Investors Chronicle is at best delayed intraday data and not "real time". Share price information may be rounded up/down and therefore not entirely accurate. Investors Chronicle is not responsible for any use of content by you outside its scope as stated in the Investors Chronicle Terms & Condition.